{"id":"W2892202190","doi":"10.1200/jco.2018.36.15_suppl.7534","title":"Improving outcomes with brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Brentuximab vedotin; Neutropenia; Internal medicine; ABVD; Dacarbazine; Febrile neutropenia; Chemotherapy regimen; Surgery; Gastroenterology; Chemotherapy; Lymphoma; Hodgkin lymphoma; Vincristine; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007743443,0.0001865754,0.0005156558,0.0001992483,0.0001650492,0.0004040794,0.0001893968,0.0002197369,0.001052282],"category_scores_gemma":[0.001098559,0.00009089128,0.0004992394,0.0002864157,0.0001525138,0.0003294092,0.0003050647,0.0005155919,0.0001191057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005322374,"about_ca_system_score_gemma":0.0005206388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000886594,"about_ca_topic_score_gemma":0.002537766,"domain_scores_codex":[0.9997008,0.0001348016,0.00002220742,0.00004091908,0.00003767906,0.00006364746],"domain_scores_gemma":[0.9995189,0.00008934081,0.0001514404,0.00001745944,0.00001620843,0.0002067122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3027193,0.008258398,0.2725059,0.0009893534,0.002285705,0.0002340684,0.0002736544,0.002840545,0.005475244,0.0002521812,0.004036839,0.4001288],"study_design_scores_gemma":[0.05492309,0.2082621,0.7258476,0.0002326074,0.001879805,0.0003585461,0.0001860207,0.002186222,0.001133393,0.0004598022,0.004508214,0.00002250787],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996392,0.002411488,0.00008143628,0.0002102509,0.00003649273,0.0001036002,0.0001792662,0.000008980654,0.0005765829],"genre_scores_gemma":[0.9984552,0.0006735057,0.000131442,0.0001691945,0.0000439654,0.00006936096,0.0002883939,0.000001409319,0.0001675574],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001052282,"threshold_uncertainty_score":0.004095137,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03357932821953199,"score_gpt":0.3837629391096827,"score_spread":0.3501836108901508,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}